Riskpilot← Back to searchSign inGet full accessÖgonläkare Öhnell AB
ABActiveOrg 5591625115Gärsgatan 2Medical specialists activities · NACE 8622Est. 20180 employees
Revenue 2024
SEK 6K
-20% vs 2023
EBITDA margin
78.6%
-24% vs 2023
Equity ratio
90.4%
Financial strength
Net profit 2024
SEK 3K
-23% vs 2023
| Revenue | SEK 6K | -20% |
| EBITDA | SEK 4K | -24% |
| Net profit | SEK 3K | -23% |
| Total assets | SEK 150K | +2% |
| Equity | SEK 136K | +3% |
| Employees | 0 | — |
Legal name
Ögonläkare Öhnell AB
Org number
5591625115
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
15 juni 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är sjukvård, utbildning, handel med värdepapper och därmed förenlig verksamhet.
Address
Gärsgatan 2
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 27 | 10 | 7 | 6 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −5 | 27 | 9 | 6 | 4 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −5 | 27 | 9 | 6 | 4 |
| Net financials | — | — | — | −0 | −0 |
| Profit before tax | −5 | 27 | 9 | 6 | 4 |
| Tax | −0 | −5 | −2 | −1 | −1 |
| Net profit | −5 | 22 | 7 | 5 | 3 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 111 | 144 | 149 | 147 | 150 |
| Equity | 98 | 121 | 128 | 132 | 136 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 12 | 24 | 22 | 15 | 14 |
| Total debt | 12 | 24 | 22 | 15 | 14 |
EBITDA margin
78.6%
This company
15.8%
Market median
+397% vs market
20202024
Equity ratio
90.4%
This company
38.2%
Market median
+137% vs market
20202024
Return on equity
2.6%
This company
18.4%
Market median
-86% vs market
20202024
Net profit margin
62.2%
This company
8.1%
Market median
+668% vs market
20202024
Asset turnover
0.04×
This company
1.12×
Market median
-96% vs market
20202024
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
LH Audit | Audit | 2020 – 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Former (2) | ||
| Board of Directors | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ögonläkare Öhnell AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Håkan Uddström | Audit | 0 companies |
| Nils Gustav Öhnell | Deputy Board Member | 0 companies |
| Inger Kersti Margareta Björkeborn | Board of Directors | 0 companies |
| Mikael Anders Gustaf Björkeborn | Deputy Board Member | 0 companies |
| Hanna Maria Viktoria Öhnell | Board of Directors | 0 companies |